The Canadian Prospective Cohort Study to understand progression in multiple sclerosis: baseline characteristics.
Jiwon OhNathalie ArbourFabrizio GiulianiMelanie GuenetteShannon KolindLarry LyndKathryn C FitzgeraldLuanne M MetzAlexandre PratAlice SchabasPenelope SmythRoger TamAnthony TraboulseeVoon Wee YongScott B PattenPublished in: Therapeutic advances in neurological disorders (2024)
Physical and mental neurological disability is prevalent even in the earliest stages of MS. Transdisciplinary approaches such as those used in CanProCo are needed to better characterize clinical progression in MS. Additional CanProCo results, including MRI, biological, and pharmaco-economic data will be forthcoming. Going forward, CanProCo's data sharing and collaborative vision will facilitate numerous global collaborations, which will inform the development and implementation of effective interventions for people with MS around the world.